Patents by Inventor Aliou Mamadou Balde

Aliou Mamadou Balde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10517826
    Abstract: A pharmaceutical composition based on Anthostema senegalense is used as a drug in the treatment of HIV infection, AIDS and accompanying clinical manifestations. The composition can be used as an antiretroviral drug against HIV type 1 or HIV type 2. The composition includes polar and/or apolar plant extract of Anthostema senegalense, preferable obtained from the stem bark of Anthostema senegalense. The composition is preferably formulated in the form of microspheres produced using an extrusion and spheronization method, and then grouped together in capsules.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: December 31, 2019
    Assignee: LABORATOIRE MICHEL IDERNE
    Inventor: Aliou Mamadou Balde
  • Publication number: 20190350995
    Abstract: The present invention relates to a chemical composition characterized in that it comprises:—the molecule A or a physiologically acceptable salt thereof, and/or:—the molecule B or a physiologically acceptable salt thereof, said molecule A having the following formula: and the molecule B having the following formula: the molecule A or a physiologically acceptable salt thereof being biologically active and stimulating immune activity, the molecule B or a physiologically acceptable salt thereof being biologically active and stimulating immune activity.
    Type: Application
    Filed: October 20, 2017
    Publication date: November 21, 2019
    Applicant: LABORATOIRE MICHEL IDERNE
    Inventor: Aliou Mamadou Balde
  • Publication number: 20170326070
    Abstract: A pharmaceutical composition based on Anthostema senegalense is used as a drug in the treatment of HIV infection, AIDS and accompanying clinical manifestations. The composition can be used as an antiretroviral drug against HIV type 1 or HIV type 2. The composition includes polar and/or apolar plant extract of Anthostema senegalense, preferable obtained from the stem bark of Anthostema senegalense. The composition is preferably formulated in the form of microspheres produced using an extrusion and spheronization method, and then grouped together in capsules.
    Type: Application
    Filed: February 20, 2015
    Publication date: November 16, 2017
    Inventor: Aliou Mamadou BALDE
  • Patent number: 8703213
    Abstract: The invention relates to a pharmaceutical antidiabetic composition containing, among the active ingredients thereof, a plant extract of Englerina lecardii, preferably a hydroalcoholic extract of Englerina lecardii leaves. The composition is preferably formulated in the form of microspheres produced using an extrusion and spheronisation method, and then grouped together in capsules. In particular, the composition is intended for cases of type 2 diabetes.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: April 22, 2014
    Inventor: Aliou Mamadou Balde
  • Publication number: 20120315327
    Abstract: The invention relates to a pharmaceutical antidiabetic composition containing, among the active ingredients thereof, a plant extract of Englerina lecardii, preferably a hydroalcoholic extract of Englerina lecardii leaves. The composition is preferably formulated in the form of microspheres produced using an extrusion and spheronisation method, and then grouped together in capsules. In particular, the composition is intended for cases of type 2 diabetes.
    Type: Application
    Filed: November 23, 2010
    Publication date: December 13, 2012
    Inventor: Aliou Mamadou Balde